# Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir

> **NCT00799760** · PHASE3 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 541 (actual)

## Conditions studied

- Gastric Influenza

## Interventions

- **DRUG:** oseltamivir + zanamivir
- **DRUG:** oseltamivir + zanamivir's placebo
- **DRUG:** oseltamivir's placebo + zanamivir

## Key facts

- **NCT ID:** NCT00799760
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2009-11
- **Final completion:** 2010-11
- **Target enrollment:** 541 (ACTUAL)
- **Why stopped:** Just Terminated for the end of the pandemia
- **Last updated:** 2012-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799760, "Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00799760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*